Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingxia Liu

Showing results (11-20 of 232) with videos related to

Pageof 24
Sort By:
Statistics in Medicine|June 5, 2019
Optimal designs in three-level cluster randomized trials with a binary outcomeJingxia Liu, Lei Liu, Graham A Colditz
Accident; Analysis and Prevention|October 19, 2006
Comparison of methods for analyzing recurrent events data: application to the Emergency Department Visits of Pediatric Firearm VictimsHyun Ja Lim, Jingxia Liu, Marlene Melzer-Lange
Plant Diversity|August 31, 2018
Distribution of <i>Holttumochloa</i> (Poaceae: Bambusoideae) in China with description of a new species revealed by morphological and molecular evidenceMengyuan Zhou, Jingxia Liu, Yiwen Liang, et al.
Water Research|July 17, 2007
Quantitative study of the effect of electromagnetic field on scale deposition on nanofiltration membranes via UTDRJianxin Li, Jingxia Liu, Tao Yang, et al.
The Laryngoscope|September 2, 2011
Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancerJason T Rich, Jingxia Liu, Bruce H Haughey
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 3, 2013
The persistence of symptom burden: symptom experience and quality of life of cancer patients across one yearTeresa L Deshields, Patricia Potter, Sarah Olsen, et al.
The Lancet. Oncology|June 8, 2024
Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trialDouglas Adkins, Jessica C Ley, Jingxia Liu, et al.
Archives of Pathology & Laboratory Medicine|July 20, 2021
Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor UseRehan Rais, Nikolaos A Trikalinos, Jingxia Liu, et al.
Statistical Methods in Medical Research|August 11, 2025
Selecting the optimal longitudinal cluster randomized design with a continuous outcome: Parallel-arm, crossover, or stepped-wedgeJingxia Liu, Fan Li, Siobhan Sutcliffe, et al.
JCO Oncology Advances|August 20, 2025
Olaparib, Pembrolizumab, and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase II TrialDouglas Adkins, Jessica C Ley, Jingxia Liu, et al.
Pageof 24

Showing results (11-20 of 232) with videos related to

Sort By:
Pageof 24
Statistics in Medicine|June 5, 2019
Optimal designs in three-level cluster randomized trials with a binary outcomeJingxia Liu, Lei Liu, Graham A Colditz
Accident; Analysis and Prevention|October 19, 2006
Comparison of methods for analyzing recurrent events data: application to the Emergency Department Visits of Pediatric Firearm VictimsHyun Ja Lim, Jingxia Liu, Marlene Melzer-Lange
Plant Diversity|August 31, 2018
Distribution of <i>Holttumochloa</i> (Poaceae: Bambusoideae) in China with description of a new species revealed by morphological and molecular evidenceMengyuan Zhou, Jingxia Liu, Yiwen Liang, et al.
Water Research|July 17, 2007
Quantitative study of the effect of electromagnetic field on scale deposition on nanofiltration membranes via UTDRJianxin Li, Jingxia Liu, Tao Yang, et al.
The Laryngoscope|September 2, 2011
Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancerJason T Rich, Jingxia Liu, Bruce H Haughey
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 3, 2013
The persistence of symptom burden: symptom experience and quality of life of cancer patients across one yearTeresa L Deshields, Patricia Potter, Sarah Olsen, et al.
The Lancet. Oncology|June 8, 2024
Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trialDouglas Adkins, Jessica C Ley, Jingxia Liu, et al.
Archives of Pathology & Laboratory Medicine|July 20, 2021
Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor UseRehan Rais, Nikolaos A Trikalinos, Jingxia Liu, et al.
Statistical Methods in Medical Research|August 11, 2025
Selecting the optimal longitudinal cluster randomized design with a continuous outcome: Parallel-arm, crossover, or stepped-wedgeJingxia Liu, Fan Li, Siobhan Sutcliffe, et al.
JCO Oncology Advances|August 20, 2025
Olaparib, Pembrolizumab, and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase II TrialDouglas Adkins, Jessica C Ley, Jingxia Liu, et al.
Pageof 24